Considerations for sampling, testing, and reporting of SARS-CoV-2 in animals
Considerações para amostragem, teste e comunicação sobre SARS-CoV-2 em animais
Autores - Departamento de Preparação e Resiliência da OIE e pelo Grupo ad hoc da OIE sobre COVID-19 e a interface humano-animal
Abstract - COVID-19, caused by infection with SARS-CoV-2, is a human disease which most likely emerged from an animal source and through widespread human to human transmission became a pandemic. COVID-19 is a reminder of the critical importance of the One Health approach. The nature of this new zoonotic virus, its widespread distribution, and the susceptibility of some animal species to infection means that close contact between people and animals may result in animal infections. The results of laboratory and epidemiological field investigations may provide evidence to better assess the implications of widespread human SARS-CoV-2 infections for animal health and welfare, veterinary public health, and wildlife conservation. This information can support a range of risk mitigation measures. However, the decision to carry out animal sampling should have a strong rationale and consider the broader public health response to COVID-19, including the availability of resources for human sampling and public health measures in place to limit disease spread.
Further information on current knowledge about SARS-CoV-2 in animals can be found on the OIE website: https://www.oie.int/scientific-expertise/specific-information-and-recommendations/questions-and-answers-on-2019novel-coronavirus/
Further information on the public health aspects of COVID-19 can be found on the WHO website: https://www.who.int/emergencies/diseases/novel-coronavirus-2019